TY - JOUR
T1 - Validation of the supplemented Spetzler-martin grading system for brain Arteriovenous malformations in a Multicenter cohort of 1009 surgical patients
AU - Kim, Helen
AU - Abla, Adib A.
AU - Nelson, Jeffrey
AU - McCulloch, Charles E.
AU - Bervini, David
AU - Morgan, Michael K.
AU - Stapleton, Christopher
AU - Walcott, Brian P.
AU - Ogilvy, Christopher S.
AU - Spetzler, Robert F.
AU - Lawton, Michael T.
PY - 2015
Y1 - 2015
N2 - BACKGROUND: The supplementary grading system for brain arteriovenous malformations (AVMs) was introduced in 2010 as a tool for improving preoperative risk prediction and selecting surgical patients. OBJECTIVE: To demonstrate in this multicenter validation study that supplemented Spetzler-Martin (SM-Supp) grades have greater predictive accuracy than Spetzler-Martin (SM) grades alone. METHODS: Data collected from 1009 AVM patients who underwent AVM resection were used to compare the predictive powers of SM and SM-Supp grades. Patients included the original 300 University of California, San Francisco patients plus those treated thereafter (n = 117) and an additional 592 patients from 3 other centers. RESULTS: In the combined cohort, the SM-Supp system performed better than SM system alone: area under the receiver-operating characteristics curve (AUROC) = 0.75 (95% confidence interval, 0.71-0.78) for SM-Supp and AUROC = 0.69 (95% confidence interval, 0.65-0.73) for SM (P <001). Stratified analysis fitting models within 3 different follow-up groupings (<6 months,±months>2 years, and .2 years) demonstrated that the SM-Supp system performed better than SM system for both medium (AUROC = 0.71 vs 0.62; P = .003) and long (AUROC = 0.69 vs 0.58; P = .001) follow-up. Patients with SMSupp grades ≤6 had acceptably low surgical risks (0%-24%), with a significant increase in risk for grades<.6 (39%-63%). CONCLUSION: This study validates the predictive accuracy of the SM-Supp system in a multicenter cohort. An SM-Supp grade of±is a cutoff or boundary for AVM operability. Supplemented grading is currently the best method of estimating neurological outcomes after AVM surgery, and we recommend it as a starting point in the evaluation of AVM operability.
AB - BACKGROUND: The supplementary grading system for brain arteriovenous malformations (AVMs) was introduced in 2010 as a tool for improving preoperative risk prediction and selecting surgical patients. OBJECTIVE: To demonstrate in this multicenter validation study that supplemented Spetzler-Martin (SM-Supp) grades have greater predictive accuracy than Spetzler-Martin (SM) grades alone. METHODS: Data collected from 1009 AVM patients who underwent AVM resection were used to compare the predictive powers of SM and SM-Supp grades. Patients included the original 300 University of California, San Francisco patients plus those treated thereafter (n = 117) and an additional 592 patients from 3 other centers. RESULTS: In the combined cohort, the SM-Supp system performed better than SM system alone: area under the receiver-operating characteristics curve (AUROC) = 0.75 (95% confidence interval, 0.71-0.78) for SM-Supp and AUROC = 0.69 (95% confidence interval, 0.65-0.73) for SM (P <001). Stratified analysis fitting models within 3 different follow-up groupings (<6 months,±months>2 years, and .2 years) demonstrated that the SM-Supp system performed better than SM system for both medium (AUROC = 0.71 vs 0.62; P = .003) and long (AUROC = 0.69 vs 0.58; P = .001) follow-up. Patients with SMSupp grades ≤6 had acceptably low surgical risks (0%-24%), with a significant increase in risk for grades<.6 (39%-63%). CONCLUSION: This study validates the predictive accuracy of the SM-Supp system in a multicenter cohort. An SM-Supp grade of±is a cutoff or boundary for AVM operability. Supplemented grading is currently the best method of estimating neurological outcomes after AVM surgery, and we recommend it as a starting point in the evaluation of AVM operability.
UR - http://www.scopus.com/inward/record.url?scp=84926124971&partnerID=8YFLogxK
U2 - 10.1227/NEU.0000000000000556
DO - 10.1227/NEU.0000000000000556
M3 - Article
C2 - 25251197
AN - SCOPUS:84926124971
SN - 0148-396X
VL - 76
SP - 25
EP - 31
JO - Neurosurgery
JF - Neurosurgery
IS - 1
ER -